Cliff Asness’s Immunovant IMVT Stock Holding History

Cliff Asness’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$427K	Buy	+11,082	New	+$338K	﹤0.01%	3463
2024 Q4	–	Sell	-10,082	Closed	-$287K	–	2903
2024 Q3	$287K	Sell	10,082 -76,201	-88%	-$2.25M	﹤0.01%	2411
2024 Q2	$2.28M	Sell	86,283 -2,315	-3%	-$65.8K	﹤0.01%	1405
2024 Q1	$2.86M	Buy	88,598 +19,634	+28%	+$716K	﹤0.01%	1242
2023 Q4	$2.91M	Buy	68,964 +43,270	+168%	+$1.59M	0.01%	1182
2023 Q3	$986K	Sell	25,694 -34,532	-57%	-$781K	﹤0.01%	1604
2023 Q2	$1.14M	Buy	60,226 +35,501	+144%	+$662K	﹤0.01%	1498
2023 Q1	$383K	Buy	+24,725	New	+$429K	﹤0.01%	1865

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cliff Asness's IMVT Position: Q2 2026 in Review

Cliff Asness opened a new position in Immunovant (IMVT) in Q2 2026: 11,082 shares worth $427K. The stake represents ﹤0.01% of the portfolio and ranks #3463 among its holdings. This is a return to the name: Cliff Asness previously reported a position in IMVT as recently as Q3 2024.

Cliff Asness first reported a position in IMVT in Q1 2023 and has held it in 8 quarters since. The position peaked at $2.91M in Q4 2023. 224 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Cliff Asness held 11,082 shares of Immunovant worth $427K as of Q2 2026.
Immunovant was a new Cliff Asness position in Q2 2026.
Immunovant made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3463 holding.
Cliff Asness first reported a position in Immunovant in Q1 2023 and has held it in 8 quarters since.
Cliff Asness's Immunovant position peaked at $2.91M in Q4 2023.
224 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.